Siegfried Group is a leading independent provider of custom process development, scale-up and commercial manufacture of active pharmaceutical ingredients and advanced pharmaceutical intermediates as well as a manufacturer of non-patented standard APIs with its manufacturing capacities being located in Switzerland and the United States.
In addition, Siegfried is not only a recognized developer of dossier for and supplier of drug products with development and manufacutring capacities in Switzerland and Malta but also a provider of challenging contract development and contract manufacturing of solid applications and a range of related services.
The Siegfried Group is a worldwide life science company with production sites in Switzerland, Malta and the U.S. and an office in China.
Siegfried offers for drug products: contract manufacturing of oral solida, contract development of complex formulation (all forms) and portfolio of drug product under its own IP for licensing out . For drug substance: a wide opiate portfolio developed under its own IP as well as custom process development, scale-up and commercial manufacturing of APIs and advanced pahrmaceutical intermediates.
- Core Sales Territory:
Global Regulated Markets
- Formed: 1873
- Number of employees: 700